Ryan Cole
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Ryan Cole is currently Chief Operating Officer at Kezar Life Sciences, Inc. since 2026 and Chief Operating Officer at Aurinia Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Cole was Senior Auditor at Ernst & Young LLP from 2009 to 2012 and Vice President-Operations at Odonate, Inc. from 2017 to 2021.
Mr. Cole completed an undergraduate degree at Santa Clara University in 2009.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/05/2026 | 116.144 ( 0,09 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Director de Operaciones | 23/03/2026 |
| KEZAR LIFE SCIENCES, INC. | Director de Operaciones | 11/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01/05/2012 |
| ODONATE, INC. | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.